MerLion Becomes Singapore’s First Biotech To Reach Phase III Trials
This article was originally published in PharmAsia News
The company will pursue a Phase III trial for acute otitis media with a compound that is partnered with Novartis’ Alcon.
You may also be interested in...
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.